Literature DB >> 26291241

21(st) Century Cures Act: An Act of Cure or Diagnosis?

David A Brindley1,2,3,4,5,6, Zeeshaan Arshad7,8, Dee Luo9,10, Sue Dopson1, Georg Hollander11, Stephen Frost12,13, Chas Bountra7, James A Smith2,3.   

Abstract

Mesh：

Year:  2015        PMID： 26291241      PMCID： PMC4554930          DOI： 10.1089/rej.2015.1757

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN： 1549-1684            Impact factor:   4.663


× No keyword cloud information.
  9 in total

Review 1.  Recalibrating intellectual property rights to enhance translational research collaborations.

Authors:  Tania Bubela; Garret A FitzGerald; E Richard Gold
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

2.  Myriad ruling causes confusion.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2013-06-20       Impact factor: 49.962

3.  Open access chemical and clinical probes to support drug discovery.

Authors:  Aled M Edwards; Chas Bountra; David J Kerr; Timothy M Willson
Journal:  Nat Chem Biol       Date:  2009-07       Impact factor: 15.040

4.  The 21st Century Cures Act--Will It Take Us Back in Time?

Authors:  Jerry Avorn; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

5.  Young scientists lead the way on fresh ideas.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2015-02-19       Impact factor: 49.962

6.  The global intellectual property landscape of induced pluripotent stem cell technologies.

Authors:  MacKenna Roberts; Ivan B Wall; Ian Bingham; Dominic Icely; Brock Reeve; Kim Bure; Anna French; David A Brindley
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

7.  Ivacaftor: a novel gene-based therapeutic approach for cystic fibrosis.

Authors:  Michelle E Condren; Marquita D Bradshaw
Journal:  J Pediatr Pharmacol Ther       Date:  2013-01

Review 8.  Use of placebo controls in the evaluation of surgery: systematic review.

Authors:  Karolina Wartolowska; Andrew Judge; Sally Hopewell; Gary S Collins; Benjamin J F Dean; Ines Rombach; David Brindley; Julian Savulescu; David J Beard; Andrew J Carr
Journal:  BMJ       Date:  2014-05-21

9.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962
  9 in total
  2 in total

1.  A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.

Authors:  Dee Luo; James A Smith; Nick A Meadows; A Schuh; Katie E Manescu; Kim Bure; Benjamin Davies; Rob Horne; Mike Kope; David L DiGiusto; David A Brindley
Journal:  Front Genet       Date:  2016-01-28       Impact factor: 4.599

2.  NIH funding trends for neurosurgeon-scientists from 1993-2017: Biomedical workforce implications for neurooncology.

Authors:  Karim ReFaey; William D Freeman; Shashwat Tripathi; Hugo Guerrero-Cazares; Tiffany A Eatz; James F Meschia; Rickey E Carter; Leonard Petrucelli; Fredric B Meyer; Alfredo Quinones-Hinojosa
Journal:  J Neurooncol       Date:  2021-07-07       Impact factor: 4.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.